Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 12.50
0.00 (0.00%)
At close: Feb 12, 2026
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 129.72 million as of February 12, 2026. Its market cap has increased by 26.28% in one year.
Market Cap
129.72M
Enterprise Value
137.33M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.50
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 129.72M, an increase of 4,039.15%. That is a compound annual growth rate of 25.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 129.72M | 26.26% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 305.01M |
| Avacta Group | 269.00M |
| Faron Pharmaceuticals Oy | 191.04M |
| Bioventix | 90.13M |
| 4basebio | 86.67M |
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.78M |
| hVIVO | 41.16M |